1.16.1.8: [methionine synthase] reductase
This is an abbreviated version!
For detailed information about [methionine synthase] reductase, go to the full flat file.
Word Map on EC 1.16.1.8
-
1.16.1.8
-
mthfr
-
folate
-
methylenetetrahydrofolate
-
case-control
-
gg
-
hyperhomocysteinemia
-
one-carbon
-
cystathionine
-
tetrahydrofolate
-
folic
-
remethylation
-
thymidylate
-
beta-synthase
-
transcobalamin
-
methylmalonic
-
megaloblastic
-
folate-related
-
spina
-
bifida
-
cobiialamin
-
methyltetrahydrofolate
-
cobalamin-dependent
-
homocystinuria
-
gcpii
-
diagnostics
-
t-hcys
-
medicine
-
folate-metabolizing
- 1.16.1.8
- mthfr
- folate
- methylenetetrahydrofolate
-
case-control
- gg
- hyperhomocysteinemia
-
one-carbon
- cystathionine
- tetrahydrofolate
-
folic
-
remethylation
- thymidylate
- beta-synthase
-
transcobalamin
-
methylmalonic
-
megaloblastic
-
folate-related
-
spina
- bifida
-
cobiialamin
- methyltetrahydrofolate
-
cobalamin-dependent
- homocystinuria
- gcpii
- diagnostics
-
t-hcys
- medicine
-
folate-metabolizing
Reaction
2 [methionine synthase]-methylcob(III)alamin + 2 S-adenosyl-L-homocysteine + = 2 [methionine synthase]-cob(II)alamin + + + 2 S-adenosyl-L-methionine
Synonyms
EC 2.1.1.135, Methionine synthase cob(II)alamin reductase (methylating), Methionine synthase reductase, MSR, MTRR, NADPH-dependent diflavin oxidoreductase, Reductase, methionine synthase
ECTree
Advanced search results
Application
Application on EC 1.16.1.8 - [methionine synthase] reductase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
diagnostics
-
the MTRR A66G polymorphism is a potential biomarker for cancer risk
medicine
cloning of the cDNA will permit the diagnostic characterization of cblE patients and investigation of the potential role of polymorphisms of this enzyme as a risk factor in hyperhomocysteinemia-linked vascular disease
medicine
-
the common variant I22M in methionine synthase reductase combined with low vitamin B12 increases risk for spina bifida
medicine
-
variant M22/S175 is a genetic determinant of plasma homocysteine levels and has been linked to premature coronary artery disease, Downs syndrome, and neural tube defects
medicine
-
study on association of natural polymorphisms I22M (A66G) and S175L (C524T) with bone mineral density and serum osteocalcin levels. No significant association between these two polymorphisms and bone mineral density and serum osteocalcin levels, but the 66G/524C haplotype affects bone turnover rate